UNSPSC 41131904: Hematocrit measuring device

In this classification, Hematocrit measuring device connotes a system consisting of instruments, tubes, racks, and a sealer and a holder. The device is used to measure the packed red cell volume in blood to determine whether the patient's total red cell volume is normal or abnormal. Abnormal states include anemia (an abnormally low total red cell volume) and erythrocytosis (an abnormally high total red cell mass). The packed red cell volume is produced by centrifuging a given volume of blood. US FDA regulates Hematocrit measuring device under 21 CFR 864.6400 and under FDA product code JPI.

UNSPSC 41131904 Hematocrit measuring device is a Commodity code under which state and local governments procure laboratory analyzers and diagnostic equipment for blood testing, including hemoglobin analysis systems, proficiency testing samples, and consumables for ion-exchange HPLC and ICP-MS instruments used in hematology screening and pediatric lead analysis. Texas Health and Human Services Commission (HHSC) and the Department of State Health Services (DSHS) are active repeat buyers under this code, procuring both capital equipment and ongoing supplies for state laboratory facilities. Work being solicited includes turnkey hemoglobin testing analyzers with automated loading capability for high-throughput screening, custom-manufactured proficiency testing samples for quality assurance in hematology workflows, and specialized consumables such as sample probes, filters, cones, nebulizers, and solutions for ICP-MS instruments. Evaluation criteria consistently emphasize bidder qualifications, ability to meet technical performance and delivery schedules, past vendor performance, and best-value award authority rather than lowest price. Pricing is firm and fixed for contract life with Consumer Price Index adjustment rights reserved to the buyer; no substitutions are permitted without prior written approval.

Recent activity concentrates in Texas and Wisconsin. The Texas HHSC and DSHS issued an IFB (HHS0017310) on May 1, 2026, for a D-10 Hemoglobin Testing System with Rack Loader (response deadline May 18, 2026, 10:30 AM Central Time), targeting equipment replacement at the South Texas Lab in Harlingen; historical spend for similar equipment ranged $45,050 to $80,000 in fiscal year 2025. The same agencies issued an earlier IFB (HHS0017071, posted February 18, 2026, responses due March 5, 2026) for PerkinElmer ICP-MS consumables and supplies across 20 line items for blood lead screening, with historical spend of $20,000 to $30,000. The University of Wisconsin-Madison solicited custom-made Hematology/Whole Blood Chemistry Proficiency Testing Samples (RFB 2026-UWMSN-01287, posted April 3, 2026, due May 5, 2026) through ShopUW+ with contact Carla Parker at carla.parker@wisc.edu. All three solicitations were open competitive procurements with no set-aside designations specified; contracts are subject to appropriations and fund availability with no guaranteed volume.